BRPI0619641B8 - peptídeo cíclico, processo para a preparação de um peptídeo cíclico, composição, e, uso de um peptídeo cíclico - Google Patents

peptídeo cíclico, processo para a preparação de um peptídeo cíclico, composição, e, uso de um peptídeo cíclico

Info

Publication number
BRPI0619641B8
BRPI0619641B8 BRPI0619641A BRPI0619641A BRPI0619641B8 BR PI0619641 B8 BRPI0619641 B8 BR PI0619641B8 BR PI0619641 A BRPI0619641 A BR PI0619641A BR PI0619641 A BRPI0619641 A BR PI0619641A BR PI0619641 B8 BRPI0619641 B8 BR PI0619641B8
Authority
BR
Brazil
Prior art keywords
cyclic peptide
preparing
composition
peptide
cyclic
Prior art date
Application number
BRPI0619641A
Other languages
English (en)
Inventor
O' Neil Deborah
Original Assignee
Novabiotics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd
Priority claimed from PCT/GB2006/004890 external-priority patent/WO2007072037A1/en
Publication of BRPI0619641A2 publication Critical patent/BRPI0619641A2/pt
Publication of BRPI0619641B1 publication Critical patent/BRPI0619641B1/pt
Publication of BRPI0619641B8 publication Critical patent/BRPI0619641B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

peptídeo cíclico ou variante do mesmo, processo para a preaparação de um peptídeo, peptídeo ciclizado, composição, uso de um peptídeo cíclico ou variante do mesmo, e, método para tratar ou prevenir uma infecção microbiana em um indivíduo. a presente invenção se refere a peptídeos catiônicos e seu uso no tratamento de infecções microbianas.
BRPI0619641A 2005-12-22 2006-12-21 peptídeo cíclico, processo para a preparação de um peptídeo cíclico, composição, e, uso de um peptídeo cíclico BRPI0619641B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0526120.1 2005-12-22
GBGB0526120.1A GB0526120D0 (en) 2005-12-22 2005-12-22 Therapeutic peptides
US77650506P 2006-02-24 2006-02-24
US60/776505 2006-02-24
PCT/GB2006/004890 WO2007072037A1 (en) 2005-12-22 2006-12-21 Cyclic antimicrobial peptides

Publications (3)

Publication Number Publication Date
BRPI0619641A2 BRPI0619641A2 (pt) 2012-12-11
BRPI0619641B1 BRPI0619641B1 (pt) 2018-01-09
BRPI0619641B8 true BRPI0619641B8 (pt) 2021-05-25

Family

ID=35840966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619641A BRPI0619641B8 (pt) 2005-12-22 2006-12-21 peptídeo cíclico, processo para a preparação de um peptídeo cíclico, composição, e, uso de um peptídeo cíclico

Country Status (10)

Country Link
CN (2) CN101389642B (pt)
BR (1) BRPI0619641B8 (pt)
DK (1) DK1976863T3 (pt)
ES (1) ES2400734T3 (pt)
GB (1) GB0526120D0 (pt)
NZ (1) NZ569946A (pt)
PT (1) PT1976863E (pt)
SG (1) SG10201403126RA (pt)
SI (1) SI1976863T1 (pt)
UA (1) UA97633C2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3429616T1 (sl) 2016-03-15 2021-12-31 Igor Polyakov Sestavki za zdravljenje in preprečevanje bolezni kopit in krempljev
CN111574588B (zh) * 2018-01-25 2021-11-09 中国医学科学院医药生物技术研究所 多肽及其在抗埃博拉病毒中的应用
CN111018953B (zh) * 2020-01-19 2022-08-26 安徽农业大学 具有抗真菌和清除自由基活性的环酪-异亮-亮-色-苏肽及制备方法
CN113264987B (zh) * 2021-05-31 2023-11-17 安徽农业大学 具有抗真菌和清除自由基活性的环色-苏-缬-异亮-亮肽及制备方法
CN113307848B (zh) * 2021-05-31 2023-11-17 安徽农业大学 具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
MXPA03010103A (es) * 2001-05-04 2004-03-10 Scripps Research Inst Peptidos y composiciones anti-microbianos.
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides

Also Published As

Publication number Publication date
ES2400734T3 (es) 2013-04-11
NZ569946A (en) 2011-12-22
SG10201403126RA (en) 2014-10-30
UA97633C2 (ru) 2012-03-12
PT1976863E (pt) 2013-03-05
CN101389642A (zh) 2009-03-18
GB0526120D0 (en) 2006-02-01
CN103394074B (zh) 2018-05-22
DK1976863T3 (da) 2013-03-04
CN101389642B (zh) 2013-08-07
BRPI0619641A2 (pt) 2012-12-11
SI1976863T1 (sl) 2013-04-30
BRPI0619641B1 (pt) 2018-01-09
CN103394074A (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
WO2005072826A3 (en) Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
DE60309701D1 (de) 2-ureido-6-heteroaryl-3h-benzoimidazol-4-carbonsäurederivate und verwandte verbindungen als gyrase und/oder topoisomerase iv inhibitoren zur behandlung von bakteriellen infektionen
BRPI0913300A2 (pt) composto, processo para o preparo e uso do mesmo, método de tratamento de infecção bacteriana em um animal, e, composição farmacêutica.
CY1113770T1 (el) Κυκλικα αντι-μικροβιακα πεπτιδια
BRPI0514420A (pt) peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
ATE427116T1 (de) Behandlung von bakteriellen infektionen
DE602005012276D1 (de) Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
SG158145A1 (en) Vaccines against chlamydial infection
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
BRPI0619641B8 (pt) peptídeo cíclico, processo para a preparação de um peptídeo cíclico, composição, e, uso de um peptídeo cíclico
BRPI0510016B8 (pt) vetor lentiviral recombinante, composição imunogênica e uso dos mesmos como vacina
CL2007003332A1 (es) Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
GB2453491A (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
BRPI0519355A2 (pt) compostos para tratamento contra flaviviridae
BR112013024965A2 (pt) composto, composição farmacêutica, método de tratamento de infecções virais, e, processo para preparar um composto
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
BRPI0417421A (pt) composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
AR071125A1 (es) Peptidos muy puenteados a partir de actinomadura namibiensis
ATE524488T1 (de) Lysobactinamide
TNSN06453A1 (en) Treatment of bacterial infections
DK1663233T3 (da) Anvendelse af tigecyclin, alene eller i kombination med rifampin til behandling af osteomyelitis og/eller septisk arthritis

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF